Page last updated: 2024-08-25

triheptanoin and carnitine

triheptanoin has been researched along with carnitine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Essén-Gustavsson, B; McCue, ME; Pagan, JD; Roe, CR; Valberg, SJ1
Brunengraber, H; Roe, CR1
Comhair, TM; Dejong, CH; Garcia Caraballo, SC; Koehler, SE; Lamers, WH1
Burchill, LJ; DeLany, JP; Deward, S; El-Gharbawy, AH; Gillingham, MB; Goldstein, A; Goodpaster, B; Harding, CO; Heitner, SB; Lasarev, MR; Martin, J; Matern, D; Pollaro, J; Rose, S; Shoemaker, J; Vockley, J1
Chang, IJ; Gunnarson, M; Hahn, S; Lam, C; McKean, KN; Merritt, JL; Norris, MK; Scott, AI; Sullivan, S; Sun, A; Thies, JM1
De Lonlay, P; Douillard, C; Guffon, N; Mochel, F; Schiff, M; Vianey-Saban, C1

Trials

2 trial(s) available for triheptanoin and carnitine

ArticleYear
Effect of triheptanoin on muscle metabolism during submaximal exercise in horses.
    American journal of veterinary research, 2009, Volume: 70, Issue:8

    Topics: Analysis of Variance; Animals; Blood Glucose; Carbohydrate Metabolism; Carnitine; Corn Oil; Cross-Over Studies; Horses; Insulin; Lipid Metabolism; Muscle, Skeletal; Physical Conditioning, Animal; Random Allocation; Triglycerides

2009
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
    Journal of inherited metabolic disease, 2017, Volume: 40, Issue:6

    Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Adult; Caprylates; Cardiomyopathies; Carnitine; Child; Dietary Fats; Double-Blind Method; Exercise; Fatty Acids; Female; Humans; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Nervous System Diseases; Oxidation-Reduction; Rhabdomyolysis; Triglycerides; Young Adult

2017

Other Studies

4 other study(ies) available for triheptanoin and carnitine

ArticleYear
Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience.
    Molecular genetics and metabolism, 2015, Volume: 116, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Carnitine; Child; Child, Preschool; Citric Acid; Fatty Acids; Female; Humans; Infant; Infant, Newborn; Lactic Acid; Lipid Metabolism, Inborn Errors; Malates; Male; Middle Aged; Mitochondrial Diseases; Oxidation-Reduction; Succinic Acid; Survival Analysis; Treatment Outcome; Triglycerides

2015
The odd-carbon medium-chain fatty triglyceride triheptanoin does not reduce hepatic steatosis.
    Clinical nutrition (Edinburgh, Scotland), 2017, Volume: 36, Issue:1

    Topics: Acyl-CoA Oxidase; Animals; Blood Glucose; Carnitine; CD36 Antigens; Cholesterol; Diet, High-Fat; Diet, High-Protein; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Fatty Liver; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Phosphoenolpyruvate Carboxykinase (GTP); PPAR alpha; Triglycerides; Uncoupling Protein 2

2017
Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
    JPEN. Journal of parenteral and enteral nutrition, 2021, Volume: 45, Issue:2

    Topics: Carnitine; Fatty Acids; Humans; Lipid Metabolism, Inborn Errors; Oxidation-Reduction; Triglycerides

2021
Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.
    Molecular genetics and metabolism, 2021, Volume: 132, Issue:4

    Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Adult; Carnitine; Child; Child, Preschool; Female; Humans; Infant; Male; Metabolic Diseases; Oxidation-Reduction; Quality of Life; Retrospective Studies; Treatment Outcome; Triglycerides; Young Adult

2021